Where do Candel Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Candel Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on assets	-36.5%-3.6pp	-32.9%+6.6pp	-39.5%-6.1pp	-33.4%+28.8pp	-62.3%+12.3pp
Liquidity
Current ratio	28×+14.6×	13.5×+5.2×	8.2×+1.2×	7×+2.4×	4.6×+1.9×
Quick ratio	28×+14.6×	13.5×+5.2×	8.2×+1.2×	7×+2.4×	4.6×+1.9×
Cash ratio	27.6×+14.3×	13.3×+5.4×	8×+1.1×	6.8×+2.3×	4.6×+1.9×
Leverage
Debt-to-equity	0×0.0×	0.1×0.0×	0.1×—	——	——
Debt-to-assets	0×0.0×	0×-0.1×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Interest coverage	-16.7×+6.1×	-22.8×+14.4×	-37.2×-11.7×	-25.5×-6.3×	-19.2×-3.2×
Per Share
Book value per share	$2.21+126%	$0.98-32.8%	$1.46-16.7%	$1.75+28.5%	$1.36-34.9%
Valuation
Market capitalization	$693.87M+192%	$310.18M+10.8%	$279.97M+15.2%	$243M-8.9%	$266.88M-30.9%
Enterprise value	$501.88M+220%	$193.36M-3.4%	$200.21M+32.9%	$150.65M-18.8%	$185.63M-37.1%
Price / book	5×+1.8×	6×+2.5×	3.5×—	——	——
Free cash flow yield	-7.1%+4.4pp	-12.5%-0.5pp	-12.1%+0.3pp	-12.3%-2.1pp	-10.2%-3.2pp
Earnings yield	-7.8%+8.8pp	-12.3%-4.2pp	-8.1%+1.0pp	-9.1%+5.7pp	-14.8%-0.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Candel Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Candel Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Candel Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.